Macrae Sandy insider trades
Macrae Sandy has filed 22 Form 4s with the SEC that we hold, all for Sangamo Therapeutics, INC (SGMO), as PRESIDENT, CEO AND DIRECTOR, Director. None of these filings reports a purchase (code P) or sale (code S) of common stock; they cover grants, option exercises and other codes. The first filing on our record is dated 2022-03-01 and the latest 2026-05-27.
Sangamo Therapeutics, INC (SGMO)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1675687) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms